Adrian Schwarzer
Greifswald, MV, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
A Clinically Applicable Unmixing Approach for Spectral MRD Detection in AML.
Journal: Cancers
Published: June 02, 2026
Donor-Derived Clonal Haematopoiesis after Allogeneic Stem-Cell Transplantation: A Case Report.
Journal: Acta haematologica
Published: March 27, 2025
Metastatic melanoma presenting with leucoerythroblastic blood film.
Journal: British journal of haematology
Published: January 15, 2025
IFN-γ-Induced CD317 Tethers Extracellular Vesicles to Mesenchymal Stromal Cells Interfering With Immune Modulation.
Journal: Journal of extracellular vesicles
Published: February 07, 2024
A 19-color single-tube full spectrum flow cytometry assay for the detection of measurable residual disease in acute myeloid leukemia.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: July 10, 2023
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Journal: Haematologica
Published: February 08, 2023
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1.
Journal: Molecular cancer therapeutics
Published: November 22, 2022
Development of an in vitro genotoxicity assay to detect retroviral vector-induced lymphoid insertional mutants.
Journal: Molecular therapy. Methods & clinical development
Published: October 24, 2022
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis.
Journal: Frontiers in oncology
Published: February 01, 2022
Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia.
Journal: Leukemia
Published: November 03, 2021
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.
Journal: HemaSphere
Published: July 29, 2021
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.
Journal: Blood
Published: June 01, 2021
Last Updated: 09/26/2026